Change search
ReferencesLink to record
Permanent link

Direct link
Differences in human papillomavirus type may influence clinical outcome in early stage cervical cancer.
Karolinska Instituet, Institutionen för Onkologi-Patologi.
Show others and affiliations
2006 (English)In: Anticancer Research, ISSN 0250-7005, Vol. 26, no 2A, 829-32 p.Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: The presence of human papillomavirus (HPV), the HPV type and viral load in early stage cervical carcinoma were investigated in order to elucidate whether any of these factors were important for clinical outcome.

PATIENTS AND METHODS: Twelve patients who were disease-free 5 years after diagnosis were matched and compared with 12 patients who died within 2 years. The presence of HPV, HPV type and viral load in their tumours was examined by PCR.

RESULTS: The distribution and load of HPV was similar in the 2 patient groups. HPV-16 was, however, significantly more common in tumours of the surviving patients than in those of patients who died (88.9% and 18.2%, respectively, p = 0.0152).

CONCLUSION: HPV-16 was significantly more common in early stage carcinomas of patients surviving more than 5 years in comparison to early stage carcinomas of patients with a poor prognosis.

Place, publisher, year, edition, pages
2006. Vol. 26, no 2A, 829-32 p.
National Category
Cancer and Oncology
Research subject
URN: urn:nbn:se:umu:diva-48180PubMedID: 16619476OAI: diva2:446986
Available from: 2011-10-10 Created: 2011-10-10 Last updated: 2011-11-11

Open Access in DiVA

No full text


Search in DiVA

By author/editor
Lindquist, David
In the same journal
Anticancer Research
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 28 hits
ReferencesLink to record
Permanent link

Direct link